Оцінка фармакотерапії дітей з хронічним гастродуоденітом в умовах реальної клінічної практики

Abstract

The evaluation of pharmacotherapy of the chronic gastroduodenitis in children, who underwent treatment in gastroenterological department of one of the health care institutions in Kharkov, has been carried out by means of supplementary clinical and economic methods: ABC- and frequency analysis. According to the results of frequency analysis was determined that the dominant direction of treatment of children with chronic gastroduodenitis in that health care institution is pathogenetic therapy of basic disease (chronic gastroduodenitis) and concomitant gastroenterological pathology. It has been established that a significant part of (35,13 %) of funds which were spent on pharmacotherapy, is associated with two medicines: "Smecta" (group "Other intestinal adsorbents ") and "Iberogast" (a group of drugs for functional gastrointestinal disorders). Comparison of the results of the ABC- and frequency analysis showed that the main funds associated with pharmacotherapy of children with chronic gastroduodenitis in that health care institution has been spent on frequently prescribed drugs: drugs of the most costly group A were prescribed almost half of all patients (48,90 %).